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Abstract Atopy is a predisposition to hyperproduction of
immunoglobulin E (IgE) against common environmental
allergens. It is often associated with development of allergic
diseases such as asthma, rhinitis, and dermatitis. Production
of IgE is influenced by genetic and environmental factors.
In spite of progress in the study of heredity of atopy, the
genetic mechanisms of IgE regulation have not yet been
completely elucidated. The analysis of complex traits can
benefit considerably from integration of human and mouse
genetics. Previously, we mapped a mouse IgE-controlling
locus Lmr9 on chromosome 4 to a segment of <9 Mb. In
this study, we tested levels of total IgE and 25 specific IgEs
against inhalant and food allergens in 67 Czech atopic
families. In the position homologous to Lmr9 on chromo-
some 8q12 marked by D8S285, we demonstrated a novel
human IgE-controlling locus exhibiting suggestive linkage
to composite inhalant allergic sensitization (limit of
detection, LOD=2.11, P=0.0009) and to nine specific
IgEs, with maximum LOD (LOD=2.42, P=0.0004) to
plantain. We also tested 16 markers at previously reported
chromosomal regions of atopy. Linkage to plant allergens
exceeding the LOD>2.0 was detected at 5q33 (D5S1507,
LOD=2.11, P=0.0009) and 13q14 (D13S165, LOD=2.74,
P=0.0002). The significant association with plant allergens
(quantitative and discrete traits) was found at 7p14
(D7S2250, corrected P=0.026) and 12q13 (D12S1298,
corrected P=0.043). Thus, the finding of linkage on
chromosome 8q12 shows precision and predictive power
of mouse models in the investigation of complex traits in
humans. Our results also confirm the role of loci at 5q33,
7p14, 12q14, and 13q13 in control of IgE.
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Introduction
Atopy is a complex trait characterized by predisposition to
hyperproduction of immunoglobulin E (IgE) against com-
mon environmental allergens. It is a major risk factor for
the development of allergic diseases such as asthma,
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rhinitis, and dermatitis. The susceptibility to atopic diseases
has an important hereditary component. In the past 12 years,
a number of genome-wide studies of atopy in humans
identified several IgE-controlling loci and genes on different
chromosomes (reviewed in Ober and Hoffjan 2006; Vercelli
2008). Some of these genes or loci were found to regulate
susceptibility to atopic diseases in several populations,
whereas others have been detected in one or a few
populations only (reviewed in Ober and Hoffjan 2006).
These controlling loci in most cases contain a number of
genes, and it is not known which of them is responsible for
the observed effects. It was suggested that in different
populations, different genes from the same chromosomal
region may be involved in control of susceptibility
(reviewed in Ober and Hoffjan 2006; Zhang et al. 2008).
The most often detected linkages were to chromosomal
regions 5q (Xu et al. 2000; Yokouchi et al. 2000, 2002;
Haagerup et al. 2002; Koppelman et al. 2002), 6p (Daniels
et al. 1996; Wjst et al. 1999; Haagerup et al. 2002; Fereira
et al. 2005), 7p (Daniels et al. 1996; Laitinen et al. 2001;
Shugart et al. 2001; Altmüller et al. 2005), 7q (Xu et al.
2000; Koppelman et al. 2002; Altmüller et al. 2005), 11q
(Daniels et al. 1996; Shugart et al. 2001; Altmüller et al.
2005), 12q (Xu et al. 2000; Koppelman et al. 2002;
Yokouchi et al. 2002), and 16q (Daniels et al. 1996; Ober
et al. 2000; Kurz et al. 2005). Positional cloning indicated
six genes at loci 2q14 (DPP10—dipeptidyl serine protease;
Allen et al. 2003), 2q33 (CTLA4—cytotoxic T-lymphocyte-
associated-4 gene; Howard et al. 2002), 5q32-33 (PCDH1—
protocadherin-1; Whittaker 2003), 7p14.3 (GPRA—G-protein-
coupled receptor; Laitinen et al. 2004), 13q14 (PHF11—PHD
finger protein 11; Zhang et al. 2003), and 20p13 (ADAM33—
Zn-dependent metalloproteinase; van Eerdewegh et al. 2002)
predisposing for atopy or atopy-associated traits. Genome-
wide association mapping led to the identification of the genes
ORMDL3 (an endoplasmic reticulum membrane protein) at
locus 17q21 (Moffatt et al. 2007) and CHI3L1 (chitinase 3-
like 1) at locus 1q32.1 (Ober et al. 2008) that contribute to the
risk of asthma.
Despite this remarkable progress in the identification of
genes controlling atopy and asthma in humans, the
complete elucidation of its genetics is hindered by many
factors including sample size, genetic heterogeneity of
human populations, gene interactions, low frequency and/
or incomplete penentrance of trait-controlling alleles, and a
high variability of environmental factors (Lander and
Schork 1994).
Some limitations of human genetic studies could be
overcome by the use of mouse models. The availability of
genetically homogenous mouse strains and possibility of
testing large numbers of F2 and backcross mice in a
controlled environment that reduces the phenotypic vari-
ance makes the mouse a useful model for study of the
complex traits in human (Lipoldová and Demant 2006).
Once the genetic regions of interest have been identified in
mouse, the high level of synteny between many mouse and
human chromosomal segments allows predicting their loca-
tions in human (DeBry and Seldin 1996). A mouse model has
been successfully applied for the identification of human
homologues of mouse asthma genes Tim1 and Tim3 in Tapr
(an airway hyperreactivity regulatory) locus at chromosomes
5q33.2 and 5q33.3, respectively (McIntire et al. 2001).
In our previous genome-wide search performed in
mouse, we described nine genetic loci on chromosomes 1,
2, 3, 4, 5, 8, 10, 16, and 18 that control IgE level
(Lipoldová et al. 2000; Badalová et al. 2002). This search
did not target certain genes throughout the genome, but a
set of genetic regions of total length of about 360 Mb.
These regions are distributed randomly in the tested
recombinant congenic (RC) strains. It must be emphasized
that this occurred without any previous selection and
without any prior knowledge about the gene content of
these regions. The description of the principle of construc-
tion of RC strains is described in Demant and Hart (1986)
and Lipoldová and Demant (2006). Subsequently, we used
the homology between genetic maps of mouse and human
to identify the corresponding orthologous regions on human
chromosomes and found that the loci Lmr3, Lmr5, Lmr8,
Lmr10, Lmr11, Lmr13, and Lmr14 (Lipoldová et al. 2000;
Badalová et al. 2002) are located in the regions homolo-
gous with the human chromosomal segments known to
control serum IgE in human atopic diseases (Wjst et al.
1999; Dizier et al. 2000; Xu at al. 2000, 2001; Yokouchi
et al. 2000, 2002; Koppelman et al. 2002), indicating a
likely relatedness of IgE-controlling genes in the two
species. However, for two loci (Lmr9 and Lmr12; Badalová
et al. 2002) described by us, the homologous human
regions have not been connected with atopy. These two
loci may point to hitherto undetected human genes that are
relevant for atopy. As Lmr12 maps to a broad segment, we
used for further study the locus Lmr9, which is rather
precisely mapped to a segment with the most likely length
of 3.58 Mb and maximal possible length of 9.32 Mb on
chromosome 4 in the strain CcS-20. The mice homozygous
for BALB/c (high IgE responder) and STS/A (low IgE
responder) alleles at this locus differed 1.6 times in IgE
level (corrected P value 0.00313; Badalová et al. 2002). In
the orthologous region on human chromosome 8q12, we
selected three short tandem repeat (STR) markers,
D8S1828 (56.96 Mb), D8S285 (57.22 Mb), and D8S1816
(57.52 Mb; Fig. 1), and tested their non-parametric linkage
and association (quantitative and discrete traits, QTDT)
with inhalant and food atopy and with levels of total IgE
and specific IgEs to 20 inhalant and five food allergens in
the 67 Czech atopic nuclear families comprising 276
subjects. In order to define other loci that may control IgE
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in Czech atopic patients, we also selected markers in
additional 16 candidate chromosomal regions for linkage
and association testing with the atopic phenotypes (Table 1).
These additional regions were previously shown to be
linked or associated with atopy and/or asthma (Daniels
et al. 1996; Wjst et al. 1999; Ober et al. 2000; Xu et al.
2000; Yokouchi et al. 2000, 2002; Laitinen et al. 2001;
Shugart at al. 2001; Haagerup at al. 2002; Koppelman et al.
2002; van Eerdewegh et al. 2002; Allen et al. 2003;
Altmüller et al. 2005; Ferreira at al. 2005; Kurz et al. 2005).
Hence, in the present study, instead of performing total
genome scans in the analyzed families, we tested only the
markers in the chromosomal regions that were either
previously shown to define linkages in humans or repre-
Fig. 1 Conserved synteny between the mouse and human genome
regions. The region on recombinant mouse chromosome 4 (Lmr9
locus) is homologous to the region on human chromosome 8q12. In
the mouse chromosomal map, the segments of BALB/c origin, where
the Lmr9 locus is excluded, is marked open. The segment of STS
origin, containing the Lmr9 gene, is marked closed. The gray segment
indicates region of undetermined origin. The most likely and the
maximal lengths of Lmr9 locus in mouse are 3.58 and 9.32 Mb,
respectively. The 530 Kb region shown in detail encompasses genes in
the close vicinity of the marker D4Mit149. The position of the marker
is given as 0 cM because it has not yet been separated from the
centromere by recombination (http://www.informatics.jax.org/, August
25, 2008). The markers in the segment on human chromosome 8 were
selected so that one is located in the center of the ±5 Mb region
orthologous to Lmr9 (D8S285) and the two other markers are
approximately equidistant centromerically (D8S1828, 260 kb) and
telomerically (D8S1816, distance 300 kb; NCBI Homology Maps
page—http://www.ncbi.nlm.nih.gov/projects/homology/maps/)
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sentative markers in the human chromosomal region that is




Nuclear families from the Czech Republic (67 families,
n=276) originated from Prague (47 families, n=192) and
from towns Ústí nad Labem, Teplice and Most (13 families,
n=55) and Trutnov (7 families, n=29), all located within
less than 120 km from Prague. The families were collected
through probands registered in local clinics as patients
with a medical history of atopic disease. All available
families were recruited into the study with the exception of
8% of families, which declined to participate for different
reasons. The probands were not ascertained for another
disorder.
The 67 nuclear atopic families contained 276 subjects,
138 of whom were offspring (Table 2, Electronic supple-
mentary material Table 1). There was no stated relatedness
between families. The mean and median age of the parents
were 43.4 and 42.0 years, respectively, and that of the
offspring were 15.9 and 14.0, respectively. The sex ratio of
the offspring was 0.53:0.47 (male to female). The percent-
age of the allergen-sensitized subjects among parents was
84.8% and among offspring 87.7%.
All participants (offspring and spouses) have under-
gone clinical examination under the protocol approved
by the Ethical Committee of the Third Faculty of
Medicine, Charles University, Prague, Czech Republic.
A full explanation of the study design was given to all
participants, and subsequently, a written consent was
obtained. Clinical specialists performed a structured
interview with each participant (or his/her guardians),
verified or newly established the diagnosis of asthma,
rhinitis, dermatitis, conjunctivitis and/or urticaria accord-
ing to EAACI guidelines (Johansson et al. 2001), and
completed a questionnaire about the disease manifesta-
tions and smoking status.
Estimation of total and specific IgE levels
The collection of blood samples was conducted from
February 1999 to February 2001. No blood samples were
collected during the summer months. The sera were stored
at −70°C before use. The total IgE level was estimated in
by CAP-FEIA (Pharmacia, Uppsala, Sweden). Specific IgE
was measured by the in vitro test system EUROLINE
(EUROIMMUN, Medizinische Labordiagnostika GmbH,
Lübeck, Germany) according to the instructions of the
manufacturer. In this system, allergen extracts were used for
the detection of specific IgEs. The lowest threshold of
detection was 0.35 kU/l. We have tested 20 inhalant and five
food allergens. Sensitization to moulds (m6—Alternaria
alternata, m3—Aspergillus fumigatus, m2—Cladosporium
Table 1 List of markers tested for linkage and association with asthma, rhinitis and dermatitis, total IgE, and specific IgE to 20 inhalant and five
food allergens
Marker Chromosomea cM (Marshfield) Reference
D2S308 2q14.3 124.03 Allen et al. 2003
D5S816 5q31.1 139.33 Koppelman et al. 2002
D5S1507 5q33.3 157.57 Yokouchi et al. 2000
D6S291 6p21 49.50 Wjst et al. 1999
D7S2250 7p14.1 54.11 Daniels et al. 1996; Shugartt et al. 2001; Laitinen et al. 2001
D7S821 7q22.1 109.12 Xu et al. 2000
D8S1828 8q12 71.00 Badalová et al. 2002
D8S285 8q12 71.00 Badalová et al. 2002
D8S1816 8q12 71.00 Badalová et al. 2002
D11S2006 11q12 59.24 Adra et al. 1999
D12S1298 12q13 75.17 Barnes et al. 1996
D12S379 12q21.31 93.69 Nickel et al. 1997
D12S1059 12q22 105.18 Barnes et al. 1996
D12S1282 12q24.31 136.82 Barnes et al. 1996
D13S165 13q14 45.55 Zhang et al. 2003
D16S3253 16q21 71.77 Daniels et al. 1996
D16S539 16q23.2 124.73 Ober et al. 2000
D19S601 19q13.32 83.19 Venanzi et al. 2001
D20S473 20p13 9.53 Van Eerdewegh et al. 2002
a The chromosomal regions were found in the GDB Human Genome Database (http://www.gdb.org, May 23, 2008)
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herbatum, m1—Penicillium notatum), animals (e3—horse,
e2—dog, e1—cat), mites (d2—Dermatophagoides farinae,
d1—Dermatophagoides pteronyssinus), weeds (w9—
Plantago lanceolata, w6—Artemisia vulgaris, w1—
Ambrosia elatior), trees (t7—Quercus alba, t4—Corylus
avellana, t3—Betula verrucosa, t2—Alnus incana), and
grasses (g12—Secale cereale, g6—Phleum pratense, g3—
Dactylis glomerata, g1—Anthoxantum odoratum) was
measured by inhalation test system. We also measured
reactivity to celery (f85), potato (f35), almond (f20),
hazelnut (f17), and rice (f9). The inhalant and food atopy
were defined as sensitization to at least one of the tested
inhalant and food allergens, respectively.
Genetic markers
For the analysis, 19 STR markers located at different
chromosomes/chromosomal regions were selected (Table 1)
from the National Centre for Biotechnology Information
(NCBI) database (http://www.ncbi.nih.gov). The STR
markers are characterized in the Marshfield genetic map
and show high heterozygosity. All markers, with the
exception of the markers on chromosome 8 (D8S1828,
D8S285, and D8S1816), are located in atopy candidate
regions previously described in genome-wide studies of
atopy and/or asthma (Daniels et al. 1996; Wjst et al. 1999;
Ober et al. 2000; Xu et al. 2000; Yokouchi et al. 2000,
Table 2 Characteristics of group of 276 participants from 67 families
Group characteristics Number (%)
Nuclear atopic families 67
Subjects 276
Parents 138
Age, mean±SD, median 43.4±10.7, 42.0
Smokers among parents, n (%) 9 (6.5%)
Total IgE>100 kU/l, n (%) 60 (43.5%)
Parents with inhalant allergic sensitization 112 (81.2%)
Food-sensitized parents 52 (37.7%)
Parents with allergic asthma 27 (19.6%)
Parents with allergic rhinitis 69 (50%)
Parents with atopic dermatitis 14 (10.1%)
Offspring/Children 138
Age, mean±SD, median 15.9±8.53, 14.0
Sex, male/female 0.53:0.47
Smokers among children, n (%) 0
Children with total IgE≥100 kU/l 89 (64.5% of all children)
Four affected sibs 1
Affected sib trios 2
Affected sib pairs 23
Affected half-sibs 33
Children with inhalant allergic sensitization 109 (79.0% of all children)
Four affected sibs 3
Affected sib trios 3
Affected sib pairs 30
Affected half-sibs 28
Food-sensitized children 77 (55.8% of all children)
Affected sib trios 2
Affected sib pairs 20
Affected half-sibs 31
Children with allergic asthma 37 (26.8% of all children)
Affected sib pairs 6
Affected half-sibs 25
Children with allergic rhinitis 87 (63.0% of all children)
Four affected sibs 2
Affected sib pairs 23
Affected half-sibs 33
Children with atopic dermatitis 39 (28.3% of al children)
Affected sib pairs 8
Affected half-sibs 23
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2002; Laitinen et al. 2001; Shugart et al. 2001; Haagerup
et al. 2002; Koppelman et al. 2002; Altmüller et al. 2005;
Ferreira et al. 2005; Kurz et al. 2005) by other groups.
Markers selected in regions 2q14.3 (Allen et al. 2003),
5q31.1 (Koppelman et al. 2002), 5q33.3 (Yokouchi et al.
2000), 6p21 (Wjst et al. 1999), 7p14.1 (Daniels et al. 1996,
Laitinen et al. 2001; Shugart et al. 2001), 7q22.1 (Xu et al.
2000), 12q21.31 (Nickel et al. 1997), 16q23.2 (Ober et al.
2000), and 19q13.32 (Venanzi et al. 2001) were exactly
those that exhibited linkage or, in region 11q12 (Adra et al.
1999), were located in close proximity. Chromosome 12q
harbors multiple genetic loci related to asthma and asthma-
related phenotypes including atopy, distinct peaks of
linkage being observed in different populations (Raby et
al. 2003). Markers in regions 12q13 and 12q24 were
selected in positions that would enable to test presence of
these linkages in the studied population. Similar approach
was used in the selection of marker in 16q21 in the vicinity
of linkages detected by (Daniels et al. 1996) and (Kurz
et al. 2005). In tests of 13q14 and 20p13, we selected the
nearest STR marker to the genes PHF11 (Zhang et al. 2003)
and ADAM33 (van Eerdewegh et al. 2002), respectively.
Markers on chromosome 8q12 (D8S1828, D8S285, and
D8S1816) were chosen on the basis of our previous whole
genome search for IgE-controlling loci in mouse (Badalová
et al. 2002). The mouse locus Lmr9 (represented by marker
D4Mit149) was mapped to the centromeric part of the mouse
chromosome 4 with the most likely and maximal lengths 3.58
and 9.32 Mb, respectively, and was shown to have linkage
with IgE level (Badalová et al. 2002). The region homologous
to the mouse Lmr9 is located on human chromosome 8q12
(NCBI database), and the markers D8S1828, D8S285, and
D8S1816 were chosen for the search for IgE-controlling loci
in human. There is no LD between the regions carrying the
three STRs (UCSC Genome Browser Assembly March 2006).
Genotyping
The primer sequences were obtained from the NCBI
database. We used Cy5 carbocyanine dye 5′-end-labeled
forward primers and unlabeled reverse primers synthesized
by Generi-Biotech s.r.o. (Hradec Králové, Czech Republic)
or Sigma-Genosys, (Steinheim, Germany). DNA was
amplified in a 10-μl polymerase chain reaction (PCR)
reaction with 10 pmol/μl of forward and reverse primer,
0.2 mM concentration of each dNTP, 1.5 or 2.0 mM MgCl2
(optimized for each STR), 50 mM KCl, 20 mM Tris–HCl
(pH 8.4), and 0.1 U of Taq polymerase, recombinant
(GIBCO, Grand Island, NY, USA) and 5 ng/μl of template
DNA. The PCR reaction was performed on 0.2 ml non-
skirted 96-well U-bottom microtiter plate (ABgene, Epsom,
UK) by MJ Research Thermal Cycler PTC 100 model 96
(MJ Research, Watertown, MA, USA). The universal
program was used for DNA amplification: an initial hot
start 5 min at 94°C, followed by 39 cycles of 94°C for 20 s
for denaturing, 55°C for 20 s for annealing, 74°C for 20 s
for elongation, and finally 10 min at 72°C for final
extension. PCR products (0.25 μl) were separated by
CEQ™ 8800 Genetic Analysis System (Beckman Coulter,
Fullerton, CA, USA). All inconclusive genotypes were
excluded (less than 2.2% for each marker).
Statistical analysis
The statistical analysis included all family members (also
probands) regardless of affected status. Two different
approaches were used for statistical analysis of data. The
first approach included non-parametric linkage analysis for
co-segregation of a chromosomal region and a trait of
interest (qualitative and quantitative). The analysis is based
on the calculation of LOD score using the linear model of
Kong and Cox (1997). This method allows using small
nuclear families and calculation of linkage without
assuming the normal distribution of the studied trait. We
used the Whittemore and Halpern NPL pair statistics
(Whittemore and Halpern 1994) to test for allele sharing
among affected individuals. The computer programMERLIN
version 1.0.0-© 2000–2005 (Abecasis et al. 2002) was used
for the calculation of identical-by-descent, allele frequencies
(across all individuals), and LOD scores.
The second approach used association analysis for
QTDT. The general model of QTDT described by Abecasis
et al. (2000a, b) is applicable to the analysis of quantitative
or discrete traits in nuclear families of any size and optionally
uses parental phenotypes. We used the orthogonal model
(Abecasis et al. 2002) to perform the association analysis of
the markers as well as their allelic variants with total and
specific IgEs. Calculation was conducted by QTDT
program version 2.4.6-© 1998–2004 (Abecasis et al.
2000b). Permutation framework (100,000 permutations)
provided by QTDT program was used to obtain global
P values. These were subsequently corrected for multiple
testing by Bonferroni correction for number of tested
markers and numbers of alleles of the tested markers.
Sex and age were chosen as covariates in both non-
parametric linkage and linkage disequilibrium analysis
of the total and specific IgEs and inhalant and food
atopy. Correlation between phenotypes (sensitization to
different allergens) was estimated by the nonparametric
Spearman’s correlation analysis using STATISTICA for
Windows version 8.0 (StatSoft 1984–2008, Tulsa, OK,
USA).
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Results
8q12 is the human genetic homologue of the IgE-controling
mouse locus Lmr9
Marker D8S285, located in the human homologue of Lmr9,
showed a suggestive linkage with IgE to P. lanceolata (w9)
allergen (LOD=2.42, P=0.0004) and with a composite
phenotype–inhalant allergic sensitization (LOD=2.11,
P=0.0009; Table 3). The locus 8q12 has not been
previously reported in connection with atopy in humans.
Potential linkage with LOD>1 was also suggested to specific
IgE against moulds (A. fumigatus—m3 and C. herbatum—
m2), animal origin allergens (dog—e2 and cat—e1), mites
(D. farinae—d2 and D. pteronyssinus—d1), A. elatior (w1),
and potato (f35) allergens (Table 3). The association QTDT
analysis of the D8S285 with IgE to P. lanceolata (w9)
revealed association with the marker (P=0.0317) and with
the certain alleles of the marker (allele 112 bp P=0.0056 and
allele 114 bp P=0.0184), supporting the linkage and
suggesting that a gene controlling atopy in humans is
localized close to D8S285. However, we did not find the
significant association after adjusting for number of compar-
isons by Bonferroni correction.
We found also some evidence of linkage to the markers
D8S1828 and D8S116 on chromosome 8q12 that are
flanking D8S285. D8S1828 that is located 260 Kb centro-
merically from the marker D8S285 exhibited potential
linkage with alder allergens (A. incana—t2; LOD=1.16,
P=0.011) and with allergen of cultivated rye (S. cereale—
g12; LOD=1.11, P=0.012). The marker D8S116, located
300 Kb telomerically from the marker D8S285, showed a
weak linkage with allergens of cultivated rye (LOD=0.68,
P=0.04).
Testing of previously reported atopy-controlling regions
in the Czech population
We also tested STR markers at the human chromosomal
regions that were previously described in genome-wide
studies to control atopy in order to determine whether these
genetic loci influence IgE level in the Czech population
(Table 1).
Two loci on chromosomes 13q14 and 5q33.3 showed the
strongest linkages with IgE to plant allergens (Table 3). We
found a suggestive linkage of marker D13S165 (Zhang
et al. 2003) with IgE to A. elatior (w1) allergen (LOD=
2.74, P=0.0002). We also detected a suggestive linkage for
marker D5S1507 (Yokouchi et al. 2000) with IgE to S.
cereale (g12; LOD=2.11, P=0.0009). Finally, markers on
chromosomes 7p14.1 (D7S2250; Daniels et al. 1996;
Laitinen et al. 2001; Shugart et al. 2001) and 12q13
(D12S1298; Barnes et al. 1996) were found by QTDT assay
to be significantly associated with P. lanceolata (w9;
marker D7S2250, corrected P=0.026; allele 147bp of
marker D7S2250, corrected P=0.034) and A. vulgaris
(w6; allele 199bp of marker D12S1298, corrected P=
0.043), respectively.
Thus, two markers (D13S165 and D5D1507) were found
to have suggestive linkages, and markers D7S2250 and
D12S1298 were significantly associated with a number of
specific IgEs (Table 3). These data support the results that
have been previously published by others (see references in
Table 1 and in “Introduction”).
There was also some evidence for linkage (LOD>1)
with a number of inhalant and food allergens to the markers
D5S816 (5q31.1), D12S1059 (12q22), D16S3253 (16q21),
and D20S473 (20p13; Table 3). We did not find any
association with and any linkage exceeding the level of a
LOD>1 to the markers D2S308 (2q14.3), D6S291 (6p21),
D7S821 (7q22.1), D11S2006 (11q12), D12S379
(12q21.31), D12S1282 (12q24.31), D16S539 (16q23.2),
and D19S601 (19q13.32).
No significant linkage was found with asthma, rhinitis,
dermatitis, and total IgE. Markers D19S601 (LOD=0.70,
P=0.04), D16S539 (LOD=0.69, P=0.04), D7S2250 (LOD=
0.83, P=0.03), and D8S285 (LOD=0.38, P=0.09) showed
the highest LOD score with asthma, rhinitis, dermatitis, and
total IgE, respectively.
Discussion
Although several genome-wide linkage studies of IgE-
controlling loci in humans were conducted, our data for the
first time indicate a locus on chromosome 8q12 that could
influence development of atopy. The finding of this linkage
shows the precision and predictive power of mouse models
in investigation of the complex traits in humans.
There are no obvious candidate genes in 8q12 chromo-
somal region. In the near proximity of the marker D8S285
are localized two oncogenes: MOS (V-MOS Moloney
murine sarcoma viral oncogene homolog) and PLAG1
(Pleiomorphic adenoma gene 1). MOS exerts many cellular
functions; however, its described impact on B cell functions
is limited to B cell malignancies caused by chromosomal
translocations of this chromosomal segment (Kirsch et al.
1982). PLAG1 encodes a developmentally regulated,
SUMOylated, and phosphorylated zinc finger transcription
factor which recognizes a specific bipartite DNA consensus
sequence regulating expression of a spectrum of target
genes (Van Dyck et al. 2007). One of the target genes of
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PLAG1 is insulin-like growth factor-2 (IGF2; Van Dyck
et al. 2007), which has pleiotropic functions in immunity. It
was shown that Igf2−/− mice had decreased numbers of
B220+ dendritic cells in spleen (Hansenne et al. 2006).
Adoptive transfer of dendritic B220− cells from allergic mice
induces specific immunoglobulin E antibody against food
allergens in naïve recipients (Chambers et al. 2004), thus
showing possible pathway how could PLAG1 influence
atopy.
Another promising target for future research of this locus
is LYN kinase gene (LYN), which is mapped near marker
D8S1828 and 150 Kb proximally of the marker D8S285.
The Src tyrosine kinase Lyn is an important modulator in
the high affinity receptor for IgE (FcɛRI) signaling
(reviewed in Rivera and Olivera 2007). Lyn-deficient mice
exhibit increased serum levels of IgE, increased numbers of
mast cells, increased expression of FcɛRI on mast cells, and
other allergy-associated traits (Odom et al. 2004). Although
the etiology of the allergy-like phenotype of Lyn deficiency
is not completely understood, the regulatory role of Lyn
kinase in the development of allergy is strongly indicated
by these results. Further, dense SNP coverage, fine
mapping, expression studies, and re-sequencing of the
8q12 region are required to define the gene(s) affecting
disease susceptibility.
In pooled groups of Caucasian families recruited from
Minnesota and from 11 clinical centers in Europe,
Australia, and USA, a suggestive linkage was detected
with total serum IgE with a peak of linkage near the marker
D8S2324 (94.08 cM—Marshfield; Webb et al. 2007). This
Table 3 Specific IgE-controlling loci in the Czech atopic families
Locus cM (Marshfield) Marker LODa/P level Association (corrected P level
b) Allergen-specific IgEe
Markerc Allelesd
5q31.1 139.33 D5S816 1.77/0.002 g12—Cultivated rye
1.35/0.006 g3—Cock’s foot
1.27/0.008 g1—Sweet vernal grass




1.95/0.0014 g1—Sweet vernal grass
7p14.1 54.65 D7S2250 0.026 147 bp/0.034 w9—Plantain
8q12 71.0 D8S1828 1.16/0.011 t2—Alder
1.11/0.012 g12—Cultivated rye










12q13 75.17 D12S1298 199 bp/0.043 w6—Mugwort
12q22 105.18 D12S1059 1.12/0.012 e1—Cat
1.00/0.02 f20—Almond
13q14 45.55 D13S165 1.80/0.002 w9—Plantain
2.74/0.0002 w1—Common ragweed
16q21 71.77 D16S3253 1.33/0.007 Inhalant atopyf
1.32/0.007 Food atopyf
1.72/0.002 g3—Cock’s foot
20p13 9.53 D20S473 1.30/0.007 e3—Horse
a Only LOD scores>1.0 are shown, LOD scores >2 are shown in bold
bP values obtained by QTDT program were corrected by Bonferroni correction (see “Materials and methods”)
c Association with markers
d Association with specific allele(s)
e Phenotype is described in detail in “Materials and methods”
f Phenotypes of inhalant and food atopy are defined as sensitization to at least one of the inhalant and food allergens, respectively
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marker is located outside the <9 Mb region homologous to
mouse IgE-controlling locus Lmr9 (Fig. 1), and also 23 cM
distally, and therefore is distinct from the locus at 8q12
described here. These data suggest that two loci controlling
human IgE might be localized on chromosome 8q.
Linkage of locus 13q14 with atopy was initially detected
in atopic families from Busselton, Western Australia
(Daniels et al. 1996). Subsequent association mapping
using dense SNP map of this region postulated PDH finger
protein 11 gene (PHF11) as a gene predisposing to atopy
(Zhang et al. 2003). In our study, the marker D13S165 that
maps within 1 Kb from PHF11 gene is linked to IgE to A.
elatior (w1; Table 3), suggesting the effect of this gene on
IgE regulation in the Czech atopic patients.
Chromosomal region 5q31-33 seems to be one of the
most attractive targets for the investigation of the IgE
control in humans. This region encompasses a cluster of
pro-inflammatory cytokine genes [IL-4, IL-5, IL-9, IL-13,
IRF-1 (interferon releasing factor 1) and CSF-1R (receptor
for colony stimulating factor 1], the protein products of
which are directly involved in immune regulation. The
linkage to this locus was corroborated in multiple studies
(Marsh et al. 1994; Ober et al. 2000; Xu et al. 2000;
Haagerup et al. 2002; Koppelman et al. 2002; Yokouchi
et al. 2002). This locus also contains genes TIM1/HAVCR/
KIM1 (5q33.2) and TIM3 (5q33.3) that were shown to
control asthma and airway hyperreactivity (McIntire et al.
2001). In the present study, a marker on chromosome
5q33.3 (D5S1507) had a suggestive linkage with IgE to
allergens of S. cereale (g12) and showed a potential linkage
to allergens of Phleum pretense (g6), D. glomerata (g3),
and A. odoratum (g1; Table 3). All grass sensitization
phenotypes (g12, g6, g3, and g1) showed very high positive
correlation with each other (R=0.937–0.988) and therefore
showed very similar LOD scores with D5S1507.
QTDT analysis also revealed two atopy-associated
markers on chromosomes 7p14.1 (D7S2250) and 12q13
(D12S1298) that did not show genetic linkage with atopy
phenotype. Linkage and QTDT association analysis [Kong
and Cox linear model (Kong and Cox 1997) and Abecasis
orthogonal model (Abecasis et al. 2000a, b), respectively]
exploit two different aspects of genetic information. Thus,
the results of association and linkage analysis may, but need
not, coincide (Wills-Karp and Ewart 2004).
Remarkably, none of the loci showed a significant
linkage or association with total IgE. This might be partly
due to a high overall sensitization of Czech atopic families
that reached nearly 90% in both parents and offspring.
However, we observed that various types of the specific
IgE were controlled by different genetic loci. Thus,
sensitization to different allergens seems to be determined
by different genes. This might also partly explain differ-
ences in results obtained by different laboratories that
postulated loci controlling total IgE in humans (Hoffjan
and Ober 2002).
We did not find any linkage or association with asthma,
rhinitis, and dermatitis. This is probably due to the low
number of affected sib pairs with asthma and dermatitis in
the tested sample (please see details in “Materials and
methods”, Table 2). Moreover, asthma (Hoffjan and Ober
2002), and probably also rhinitis and dermatitis, may
comprise groups of several disorders. In the mouse model,
the various components of the pathogenetic pathway of
allergic asthma are under separate genetic control (Piavaux
et al. 2007); this may explain why in this and other similar
studies, asthma is not necessarily linked to the genes that
control one out of the multiple sets of pathogenetic
components. The analysis of less complex and more exactly
defined phenotypes such as levels of total and specific IgE
is therefore an important part of genetics of atopic diseases.
The present work demonstrates the power of the
genome-wide screening in mice in finding new loci
determining complex traits such as IgE levels in humans.
Using this approach, a new IgE-controlling locus has been
identified on chromosome 8q12 that influences the sensi-
tization to a number of allergens. Our data also confirm the
role of the previously reported loci 13q14, 5q33.3, 7p14.1,
and 12q13 in control of IgE and development of atopy.
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